KORU, Medical

KORU Medical Systems Approaches Critical Q3 Earnings Milestone

Published on 11/02/2025 at 09:10 | Redaktion boerse-global.de

Building on Record Performance

KORU Medical Systems Approaches Critical Q3 Earnings Milestone Illustration mit AI erstellt übermittelt durch boerse-global.de
KORU Medical Systems Approaches Critical Q3 Earnings Milestone Illustration mit AI erstellt übermittelt durch boerse-global.de

All eyes are on KORU Medical Systems as the medical technology firm prepares to release its third-quarter 2025 financial results on November 12. Following an exceptional previous quarter and an upgraded full-year outlook, the upcoming report represents a crucial test for the company’s sustained growth trajectory.

The company enters this earnings period with significant momentum from its second-quarter achievements. KORU Medical Systems demonstrated robust expansion across multiple segments, with total revenue climbing 21% to exceed $10 million. International operations showed particular strength, advancing 34% year-over-year, while pharmaceutical services recorded an impressive 42% growth rate.

Although gross margins experienced a modest contraction to 63.5%, the organization maintains a solid financial foundation with $8.1 million in cash reserves. Management’s Read more...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US7599101026 | KORU | boerse | 68316955 |